Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial.
Eur Heart J
; 39(5): 363-370, 2018 02 01.
Article
in En
| MEDLINE
| ID: mdl-29020355
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benzhydryl Compounds
/
Sodium-Glucose Transporter 2 Inhibitors
/
Glucosides
/
Heart Failure
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur Heart J
Year:
2018
Document type:
Article
Affiliation country:
Canadá